Integrated Core Strategies (US) LLC 13D/13G Filings for Terns Pharmaceuticals, Inc. (TERN)

Integrated Core Strategies (US) LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-06-27
4:32 pm
Purchase
2023-06-2013GTERNS PHARMACEUTICALS INC
TERN
Integrated Core Strategies (US) LLC2,313,370
4.100%
2,313,370increase
(New Position)
Filing